Bridgeway Capital Management, LLC Castle Biosciences Inc Transaction History
Bridgeway Capital Management, LLC
- $3.98 Billion
- Q2 2025
A detailed history of Bridgeway Capital Management, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 40,750 shares of CSTL stock, worth $1.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
40,750Holding current value
$1.3 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CSTL
# of Institutions
170Shares Held
27.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.04MShares$97.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$69.2 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.79MShares$57.2 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.49MShares$47.5 Million2.2% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.38MShares$43.9 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $839M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...